DZ Bank Call 42.5 VBK 20.12.2024/ DE000DJ4BP55 /
14/06/2024 13:08:52 | Chg.0.000 | Bid14/06/2024 | Demandez à14/06/2024 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | 0.001 Bid taille: 60,000 |
0.041 Ask la taille: 60,000 |
VERBIO SE INH O.N. | 42.50 - | 20/12/2024 | Call |
GlobeNewswire
13:30
JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Note...
GlobeNewswire
13:30
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evalua...
GlobeNewswire
13:30
Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective an...
GlobeNewswire
13:30
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Associatio...
GlobeNewswire
13:30
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Associatio...
GlobeNewswire
13:14
Hymson Brings its Laser Solutions for Battery Innovation to The Battery Show Europe 2024
GlobeNewswire
13:01
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 V...
GlobeNewswire
13:00
Correction: 仙境传说:破晓 (Ragnarok: Dawn, Tentative English Title) Received an ISBN from the Chinese Gove...
GlobeNewswire
13:00
Kymera Therapeutics Presents New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-3...
GlobeNewswire
13:00
Volvo Car Canada Collaborates with iconic global fashion brand to unveil curated looks inspired by t...
GlobeNewswire
13:00
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter ...
GlobeNewswire
13:00
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in ...
GlobeNewswire
13:00
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatmen...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page